Literature DB >> 16507889

Dexamethasone induces connective tissue growth factor expression in renal tubular epithelial cells in a mouse strain-specific manner.

Hirokazu Okada1, Tomohiro Kikuta, Tsutomu Inoue, Yoshihiko Kanno, Shinichi Ban, Takeshi Sugaya, Masaharu Takigawa, Hiromichi Suzuki.   

Abstract

Connective tissue growth factor (CTGF), a downstream mediator of transforming growth factor-beta1, mediates mesangial cell/fibroblast proliferation and extracellular matrix production by renal cells. Here, we show that renal tubular epithelial cells from patients with minimal change nephritic syndrome produced CTGF after glucocorticoid treatment. In addition, the glucocorticoid dexamethasone (DEX) increased CTGF mRNA levels in the kidneys of C57B6 but not SJL mice and produced intermediate CTGF mRNA levels in the kidneys of F1 (C57B6 x SJL) mice, midway between the levels found for parental strains. DEX also increased CTGF mRNA levels in cultured tubular epithelial cells derived from C57B6 (mProx24) but not SJL (MCT) mice via transcriptional up-regulation of CTGF mRNA. Transient transfection experiments using luciferase reporter constructs bearing CTGF promoter fragments revealed that the -897- to -628-bp fragment contained DEX-responsive positive regulatory elements, which were active in mProx24 but not MCT cells. Long-term DEX treatment resulted in fibronectin deposition in the kidneys of C57B6 but not SJL mice, and this effect was inhibited by co-administration of CTGF anti-sense oligodeoxynucleotides. Thus, glucocorticoid-induced renal fibrogenesis seems to be influenced by genetic background, with the critical DEX-responsive elements in the -897- to -628-bp region of the CTGF promoter.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16507889      PMCID: PMC1606512          DOI: 10.2353/ajpath.2006.050656

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  36 in total

1.  CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling.

Authors:  A Holmes; D J Abraham; S Sa; X Shiwen; C M Black; A Leask
Journal:  J Biol Chem       Date:  2001-01-04       Impact factor: 5.157

2.  Cooperative effects of STAT5 (signal transducer and activator of transcription 5) and C/EBPbeta (CCAAT/enhancer-binding protein-beta) on beta-casein gene transcription are mediated by the glucocorticoid receptor.

Authors:  S L Wyszomierski; J M Rosen
Journal:  Mol Endocrinol       Date:  2001-02

3.  Hepatocyte growth factor counteracts transforming growth factor-beta1, through attenuation of connective tissue growth factor induction, and prevents renal fibrogenesis in 5/6 nephrectomized mice.

Authors:  Tsutomu Inoue; Hirokazu Okada; Tatsuya Kobayashi; Yusuke Watanabe; Yoshihiko Kanno; Jeffrey B Kopp; Takashi Nishida; Masaharu Takigawa; Munehisa Ueno; Toshikazu Nakamura; Hiromichi Suzuki
Journal:  FASEB J       Date:  2002-12-03       Impact factor: 5.191

Review 4.  Transcriptional control mechanism of fibrinogen gene expression.

Authors:  G M Fuller; Z Zhang
Journal:  Ann N Y Acad Sci       Date:  2001       Impact factor: 5.691

Review 5.  Chronic renal diseases: renoprotective benefits of renin-angiotensin system inhibition.

Authors:  Giuseppe Remuzzi; Piero Ruggenenti; Norberto Perico
Journal:  Ann Intern Med       Date:  2002-04-16       Impact factor: 25.391

6.  Inhibition of monocyte chemoattractant protein-1 expression in tubular epithelium attenuates tubulointerstitial alteration in rat Goodpasture syndrome.

Authors:  H Okada; K Moriwaki; R Kalluri; H Imai; S Ban; M Takahama; H Suzuki
Journal:  Kidney Int       Date:  2000-03       Impact factor: 10.612

Review 7.  Connective tissue growth factor: what's in a name?

Authors:  E E Moussad; D R Brigstock
Journal:  Mol Genet Metab       Date:  2000 Sep-Oct       Impact factor: 4.797

Review 8.  Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis.

Authors:  S Gupta; M R Clarkson; J Duggan; H R Brady
Journal:  Kidney Int       Date:  2000-10       Impact factor: 10.612

9.  CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC.

Authors:  Youjun Chen; Ingrid E Blom; Susan Sa; Roel Goldschmeding; David J Abraham; Andrew Leask
Journal:  Kidney Int       Date:  2002-10       Impact factor: 10.612

10.  Differences in the fibrogenic response after transfer of active transforming growth factor-beta1 gene to lungs of "fibrosis-prone" and "fibrosis-resistant" mouse strains.

Authors:  Martin Kolb; Philippe Bonniaud; Tom Galt; Patricia J Sime; Margaret M Kelly; Peter J Margetts; Jack Gauldie
Journal:  Am J Respir Cell Mol Biol       Date:  2002-08       Impact factor: 6.914

View more
  15 in total

1.  Increased Expression of Connective Tissue Growth Factor (CTGF) in Multiple Organs After Exposure of Non-Human Primates (NHP) to Lethal Doses of Radiation.

Authors:  Pei Zhang; Wanchang Cui; Kim G Hankey; Allison M Gibbs; Cassandra P Smith; Cheryl Taylor-Howell; Sean R Kearney; Thomas J MacVittie
Journal:  Health Phys       Date:  2015-11       Impact factor: 1.316

Review 2.  Aldosterone-induced fibrosis in the kidney: questions and controversies.

Authors:  Andrew S Brem; David J Morris; Rujun Gong
Journal:  Am J Kidney Dis       Date:  2011-06-25       Impact factor: 8.860

3.  Therapeutic Modalities in Diabetic Nephropathy: Future Approaches.

Authors:  William Brian Reeves; Bishal B Rawal; Emaad M Abdel-Rahman; Alaa S Awad
Journal:  Open J Nephrol       Date:  2012-06-25

4.  Effects of mineralocorticoid receptor blockade on glucocorticoid-induced renal injury in adrenalectomized rats.

Authors:  Kazi Rafiq; Daisuke Nakano; Genei Ihara; Hirofumi Hitomi; Yoshihide Fujisawa; Naro Ohashi; Hiroyuki Kobori; Yukiko Nagai; Hideyasu Kiyomoto; Masakazu Kohno; Akira Nishiyama
Journal:  J Hypertens       Date:  2011-02       Impact factor: 4.844

5.  Poly(ADP-ribose) polymerase-1 enhances transcription of the profibrotic CCN2 gene.

Authors:  Hirokazu Okada; Tsutomu Inoue; Tomohiro Kikuta; Nobutaka Kato; Yoshihiko Kanno; Narumi Hirosawa; Yasushi Sakamoto; Takeshi Sugaya; Hiromichi Suzuki
Journal:  J Am Soc Nephrol       Date:  2008-02-20       Impact factor: 10.121

6.  Connective tissue growth factor promotes fibrosis downstream of TGFbeta and IL-6 in chronic cardiac allograft rejection.

Authors:  A J Booth; K Csencsits-Smith; S C Wood; G Lu; K E Lipson; D K Bishop
Journal:  Am J Transplant       Date:  2009-09-25       Impact factor: 8.086

Review 7.  Bone morphogenetic protein-7 and connective tissue growth factor: novel targets for treatment of renal fibrosis?

Authors:  Tri Q Nguyen; Roel Goldschmeding
Journal:  Pharm Res       Date:  2008-02-12       Impact factor: 4.200

8.  PPAR-δ activation reduces cisplatin-induced apoptosis via inhibiting p53/Bax/caspase-3 pathway without modulating autophagy in murine renal proximal tubular cells.

Authors:  Juanping Shan; Hideki Kimura; Seiji Yokoi; Kazuko Kamiyama; Toru Imamoto; Izumi Takeda; Mamiko Kobayashi; Daisuke Mikami; Naoki Takahashi; Kenji Kasuno; Takeshi Sugaya; Masayuki Iwano
Journal:  Clin Exp Nephrol       Date:  2021-03-01       Impact factor: 2.617

9.  Proteomic analysis reveals dexamethasone rescues matrix breakdown but not anabolic dysregulation in a cartilage injury model.

Authors:  Rebecca Mae Black; Yang Wang; André Struglics; Pilar Lorenzo; Viveka Tillgren; Martin Rydén; Alan J Grodzinsky; Patrik Önnerfjord
Journal:  Osteoarthr Cartil Open       Date:  2020-09-05

10.  Glucocorticoids activate TGF-beta induced PAI-1 and CTGF expression in rat hepatocytes.

Authors:  Lucia Wickert; Nicolas Chatain; Karin Kruschinsky; Axel M Gressner
Journal:  Comp Hepatol       Date:  2007-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.